HIV lipodystrophy: prevalence, severity and correlates of risk in Australia
Open Access
- 15 July 2003
- journal article
- research article
- Published by Wiley in HIV Medicine
- Vol. 4 (3) , 293-301
- https://doi.org/10.1046/j.1468-1293.2003.00159.x
Abstract
Objective To establish the prevalence, severity and factors associated with the HIV lipodystrophy syndrome. Methods Cross‐sectional study of lipodystrophy conducted in high HIV caseload primary ca...Keywords
This publication has 17 references indexed in Scilit:
- Rates of combination antiretroviral treatment change in Australia, 1997–2000HIV Medicine, 2002
- Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort StudyClinical Infectious Diseases, 2001
- Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS, 2001
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000
- Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and LipodystrophyArchives of internal medicine (1960), 2000
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Fasting Hyperinsulinemia and Changes in Regional Body Composition in Human Immunodeficiency Virus-Infected WomenJournal of Clinical Endocrinology & Metabolism, 1999
- Altering molecular mechanisms to prevent sudden arrhythmic deathThe Lancet, 1998
- Triglyceride Concentration and Ischemic Heart DiseaseCirculation, 1998
- “Buffalo hump” in men with HIV-1 infectionThe Lancet, 1998